ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MSYS Microsaic Systems Plc

0.825
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Microsaic Systems Plc LSE:MSYS London Ordinary Share GB00BMWC8365 ORD GBP0.00001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.825 0.80 0.85 0.825 0.825 0.83 125,076 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Components, Nec 492k -2.6M -0.0145 -0.57 1.48M
Microsaic Systems Plc is listed in the Electronic Components sector of the London Stock Exchange with ticker MSYS. The last closing price for Microsaic Systems was 0.83p. Over the last year, Microsaic Systems shares have traded in a share price range of 0.007p to 2,734.375p.

Microsaic Systems currently has 179,178,184 shares in issue. The market capitalisation of Microsaic Systems is £1.48 million. Microsaic Systems has a price to earnings ratio (PE ratio) of -0.57.

Microsaic Systems Share Discussion Threads

Showing 3926 to 3942 of 4600 messages
Chat Pages: Latest  160  159  158  157  156  155  154  153  152  151  150  149  Older
DateSubjectAuthorDiscuss
22/7/2021
15:13
so come on - where exactly does your hatred of G Brandon come from ?
ragnarr
21/7/2021
18:48
As a matter of interest how much did you loose out of Alltracel ?
ragnarr
21/7/2021
12:45
Great news indeed, especially for GB's very very very close friends over at TP. A off the scale almost one billion shares can be exercised within the next two years at a give away 0.1p. This equates to an instant 1 million profit at today's rates. What with recent 2 million profit from the take over of Modern Water, one assumes its great work if you can get it. I suppose also worth mentioning the fact the Modern water deal also netted the chairman of that company and the CEO of deep verge a huge pay out. Don't make the mistake of thinking it was two different people, you couldn't write it if you had tried.
cocker
21/7/2021
12:22
https://www.genengnews.com/topics/bioprocessing/microsaic-systems-goes-real-time-with-pat/
ragnarr
09/7/2021
08:23
Morning my little troll friend - Its perfectly fine to point out negative issues but for you its just this obsession/hatred with G Brandon that undermines your posts by simply repeating the same point again and again and again and you will no doubt continue to repeat - you have just become white noise.Truth teller - sadly I think you actually believe that - reality you are just the entertainment.You never answered my question over on DVRG months ago - what are you hiding.
ragnarr
08/7/2021
14:44
Still taking it all so personally I see, and wasting hours of your life trolling MSYS and DVRG
ragnarr
08/7/2021
11:07
Troll, I prefer the truth teller. Today's facts or numbers as the Leprechaun loves so much, did you know Turner Poop are entitled to exercise almost a billion warrants at 0. 1p for services rendered. Who on God's earth would buy shares in this company when associates pockets are being lined with gold.
cocker
07/7/2021
15:57
Afternoon my little troll friend.
ragnarr
07/7/2021
14:34
WOW, that almost 600 % increase is still 50% below the previous years T/O, so hardly worth a mention. It's also only 20% of annual running costs let alone the huge losses this company is piling up year on year. Probably better to point out more relevant facts like15mill mrk cap which is ridiculous and has how many billion shares in issue, with the usual warrant festival to begin.
cocker
07/7/2021
14:22
Microsaic Systems sees revenues surge by 594% in 1H21https://www.voxmarkets.co.uk/articles/microsaic-systems-sees-revenues-surge-by-594-in-1h21--efd4640/
ragnarr
06/7/2021
09:27
Jones you need to do more homework my friend. GB took a huge part in the 0.1p heavily discounted placing here, as did his wife I believe. Although if my memory serves me right the funds were from shares she sold in Deep Verge that no one knew about until the market was informed. I'm sure it was all above board and an oversite on her behalf.
cocker
06/7/2021
08:20
I wonder why the directors show so little confidence in this business ?

Holding 1 million shares looks like a lot for the CFO, but at 0.26p, that works out at about £2600. I guess he might not see it as a potential rocket stock.

The new chairman seems not to have bought any shares yet, whilst he holds £2.6m in Deep Verge, which is mentioned as a related party in the RNS today.

jonesj
06/7/2021
06:31
06/07/2021 7:00am
UK Regulatory (RNS & others)

Microsaic Systems (LSE:MSYS)
Intraday Stock Chart

Tuesday 6 July 2021

Click Here for more Microsaic Systems Charts.
TIDMMSYS

RNS Number : 2415E

Microsaic Systems plc

06 July 2021

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018) ("UK MAR").

6 July 2021

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic trading update for H1 2021

Unaudited revenues up 594% on H1 2020 and 52% on H1 2019,

reflecting new business model

Microsaic (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments is delighted to announce that a strategic change of business model early in 2021 has resulted in recovery of growth in revenues, increasing to GBP0.499m in H1 2021, significantly above H1 2020 and that of H1 2019, a pre-pandemic benchmark.

First Half Highlights:

-- Unaudited revenues of GBP0.499m
o 594% increase over H1 2020 (GBP0.072m) and 52% over H1 2019 (GBP0.328m).

-- January: transformative placing which raised GBP5.5m (gross), board changes and strategic shift away from independent development to a commercial strategy with external partners.

-- Five key commercial hires to accelerate revenues on environmental detection of water contamination and in human health markets, delivering real-time on-site monitoring and data analytics with connected Internet of Things ("IoT"), AI and support services.

-- March: commercial agreement with DeepVerge plc ("DeepVerge"; AIM: DVRG), through which Microsaic products and services are being deployed internationally in applications such as water monitoring of chemicals and pathogens, and in support of DeepVerge's rapidly growing Labskin division.

-- May: initial shipments to a new Chinese partner to obtain a medical licence in China for real-time therapeutic monitoring of drugs with commercialisation (including service and reagents revenue sharing) expected in 2022.

-- May: collaboration with Swansea University to combine real-time monitoring of environmental water using AI in determining the link between environmental chemical pollution and human health.

-- June: further order from DeepVerge under the framework agreement
Post Period Events:

-- July: The world first demonstration of real-time monitoring of on-line production of biotherapeutic drugs such as vaccines and anti-cancer treatments using Process Analytical Technology within a Microsaic micro-engineered MS solution.

Ongoing commercial developments

-- Disruptive low-cost and mobile system to detect organic chemicals in water and wastewater adapted for in-field deployment.

-- Detection of volatile contaminants in water, with product demonstration expected in H2 of this year. This significantly expands the reach of applications with mobile capability for environmental regulatory authorities.

-- Multiple collaboration projects, including in-surgery cancer diagnostics, with the aim to secure commercial supply agreements with the potential to revolutionise surgical oncology interventions.

Glenn Tracey, CEO of Microsaic Systems plc, commented:

" I am thrilled to report this transformational performance for the first half of 2021, after the effects that the COVID-19 lockdown had on our customers, employees in 2020 and the financial strain this placed on the Company. The new commercial strategy of collaborating, partnering and revenue sharing has moved the Company away from equipment-only sales. We are now offering integrated real-time data analytics with AI alongside our mass spectroscopy hardware, providing complete solutions such as in-field environmental testing and on-site human diagnostics. The change of strategy and adjustment to a revenue sharing business model has demonstrated solid evidence of sales growth which is expected to continue into H2.

Given the ongoing uncertainties over the effects of further waves of COVID-19 across multiple geographies, the Board remains cautious on short-term forecasting. Accordingly, we will consider whether it is appropriate to reinstate guidance to analysts after publication of the interim results, which is expected to take place during the autumn. However, prospects over the mid-term are looking more positive, with the encouraging first half results being more reflective of the Company's potential, and we look forward to our next scheduled performance update. "

Related party transaction

On 24 March 2021, the Company announced that it had entered into a non-exclusive Framework Services Agreement (the "Agreement") with DeepVerge. The multi-year Agreement provides for the supply by Microsaic to DeepVerge of miniaturised mass spectrometry equipment and services, across DeepVerge's sales, marketing, and distribution channels. The Agreement included an initial order of three units as well as a commitment to purchase further units in connection with the installation of pilot demonstration facilities at DeepVerge's York laboratories (together, the "Orders").

The Company has processed a further smaller purchase order from DeepVerge (the "Further Order") under the Agreement, supplying certain additional mass spectrometry equipment for quality and contamination detection in a range of markets including water and soil analysis. The value of the Further Order is approximately GBP72,000 and constitutes a related party transaction under Rule 13 of the AIM Rules. Additionally, Microsaic is loaning an additional item of equipment to DeepVerge for no consideration, to enable an early evaluation of certain technical aspects of its potential use.

At the time of entering into the Agreement, the independent directors, being Glenn Tracey and Bevan Metcalf, considered, having consulted with the Company's nominated adviser, that the terms of the Agreement, were fair and reasonable insofar as the Company's shareholders are concerned. The independent directors also consider that the terms of the Further Order are consistent with the Agreement and with the terms of the initial Orders, and therefore they consider that the terms of the Further Order continue to be fair and reasonable insofar as shareholders are concerned.

david gruen
06/7/2021
06:23
Looks very positive here
cashistrash
05/7/2021
08:14
Sold a few here today and taken profit and put into Deepverge DVRG, think Microsaic will need more money in the future, have some left though. Info on Deepverge. The impact will be good in the long run for Microsaic...
onehanded
02/7/2021
15:33
Cheers, ragnarr - appreciate the info.
daveboy19
02/7/2021
15:19
Worth a read to understand the implications of todays newsHow to Improve Productivity and Lower Costs with Real-Time Technology at the Point-of-Needhttps://www.microsaic.com/news/how-to-improve-productivity-and-lower-costs-with-real-time-technology-at-the-point-of-need/
ragnarr
Chat Pages: Latest  160  159  158  157  156  155  154  153  152  151  150  149  Older

Your Recent History